Difference between revisions of "Template:Drugs for obstructive airway diseases"
Jump to navigation
Jump to search
imported>Anypodetos m (Bypass redirects) |
|||
| Line 9: | Line 9: | ||
| group1 = [[beta2-adrenergic agonist|Short acting β<sub>2</sub>-agonists]] | | group1 = [[beta2-adrenergic agonist|Short acting β<sub>2</sub>-agonists]] | ||
| − | | list1 = [[Salbutamol]]<sup>#</sup>/[[Levosalbutamol]] • [[Fenoterol]] • [[Terbutaline]] • [[Pirbuterol]] • [[Procaterol]] • [[Bitolterol]] • [[Rimiterol]] • | + | | list1 = [[Salbutamol]]<sup>#</sup>/[[Levosalbutamol]] • [[Fenoterol]] • [[Terbutaline]] • [[Pirbuterol]] • [[Procaterol]] • [[Bitolterol]] • [[Rimiterol]] • [[Carbuterol]] • [[Tulobuterol]] • [[Reproterol]] |
| group2 = [[Long acting beta-adrenoceptor agonist|Long acting β<sub>2</sub>-agonists]] (LABA) | | group2 = [[Long acting beta-adrenoceptor agonist|Long acting β<sub>2</sub>-agonists]] (LABA) | ||
| − | | list2 = [[Arformoterol]] • [[Bambuterol]] • [[Clenbuterol]] • [[Formoterol]] • [[Salmeterol]] ''Ultra LABA:'' [[Indacaterol]] | + | | list2 = [[Arformoterol]] • [[Bambuterol]] • [[Clenbuterol]] • [[Formoterol]] • [[Salmeterol]] ''Ultra LABA:'' [[Indacaterol]] |
| group3 = other | | group3 = other | ||
| − | | list3 = [[Epinephrine]]<sup>#</sup> • [[Hexoprenaline]] • [[Isoprenaline|Isoprenaline (Isoproterenol)]] • [[Orciprenaline|Orciprenaline (Metaproterenol)]] | + | | list3 = [[Epinephrine]]<sup>#</sup> • [[Hexoprenaline]] • [[Isoprenaline|Isoprenaline (Isoproterenol)]] • [[Orciprenaline|Orciprenaline (Metaproterenol)]] |
| Line 21: | Line 21: | ||
| group2 = [[Glucocorticoid]]s | | group2 = [[Glucocorticoid]]s | ||
| − | | list2 = [[beclometasone dipropionate|Beclometasone]]<sup>#</sup> • [[Budesonide]] • [[Ciclesonide]] • [[Fluticasone]] • [[Mometasone furoate|Mometasone]] • [[Flunisolide]] • [[Betamethasone]] • [[Triamcinolone]] | + | | list2 = [[beclometasone dipropionate|Beclometasone]]<sup>#</sup> • [[Budesonide]] • [[Ciclesonide]] • [[Fluticasone]] • [[Mometasone furoate|Mometasone]] • [[Flunisolide]] • [[Betamethasone]] • [[Triamcinolone]] |
| group3 =[[Anticholinergic]]s/<BR>[[muscarinic antagonist]] | | group3 =[[Anticholinergic]]s/<BR>[[muscarinic antagonist]] | ||
| − | | list3 =[[Ipratropium]]<sup>#</sup> • [[Tiotropium]] | + | | list3 =[[Ipratropium bromide]]<sup>#</sup> • [[Tiotropium]] |
| group4 = [[Mast cell stabilizer]]s | | group4 = [[Mast cell stabilizer]]s | ||
| − | | list4 = [[Cromoglicate]] • [[Nedocromil]] | + | | list4 = [[Cromoglicate]] • [[Nedocromil]] |
| group5 = [[Xanthine]]s | | group5 = [[Xanthine]]s | ||
| − | | list5 = [[Doxofylline]] • [[Enprofylline]] • [[Theobromine]] • [[Theophylline]]/[[Aminophylline]] | + | | list5 = [[Doxofylline]] • [[Enprofylline]] • [[Theobromine]] • [[Theophylline]]/[[Aminophylline]] |
| group6 = [[Eicosanoid]] inhibition | | group6 = [[Eicosanoid]] inhibition | ||
| Line 37: | Line 37: | ||
| group1 = [[Leukotriene antagonist]]s | | group1 = [[Leukotriene antagonist]]s | ||
| − | | list1 = [[Montelukast]] • [[Pranlukast]] • [[Zafirlukast]] | + | | list1 = [[Montelukast]] • [[Pranlukast]] • [[Zafirlukast]] |
| group7 = [[Lipoxygenase inhibitor]] | | group7 = [[Lipoxygenase inhibitor]] | ||
| Line 43: | Line 43: | ||
| group8 = [[Thromboxane receptor antagonist]]s | | group8 = [[Thromboxane receptor antagonist]]s | ||
| − | | list8 = [[Ramatroban]] • [[Seratrodast]] | + | | list8 = [[Ramatroban]] • [[Seratrodast]] |
| Line 50: | Line 50: | ||
}} | }} | ||
| group9 = Combination products | | group9 = Combination products | ||
| − | | list9 = [[Budesonide/formoterol]] • [[Fluticasone/salmeterol]] • [[Ipratropium/salbutamol]] | + | | list9 = [[Budesonide/formoterol]] • [[Fluticasone/salmeterol]] • [[Ipratropium bromide/salbutamol]] |
| list10 = | | list10 = | ||